Sign In
Buy MYL
$15.86
+0 (+0%)
At Close: May 27, 2022
Slate Path Capital LP Buys Mylan NV, Ironwood Pharmaceuticals Inc, Pan American Silver Corp, ...
12:00am, Friday, 15'th May 2020Mylan to Present at the 2020 RBC Capital Markets' Virtual Global Healthcare Conference
04:23pm, Wednesday, 13'th May 2020
Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that Executive Chairman Robert J. Coury and President Rajiv Malik will present at the 2020 RBC Capital Markets' Virtual Global He
UBS Maintains Neutral on Mylan, Raises Price Target to $17
12:00am, Wednesday, 13'th May 2020Gilead Strikes Deal With Mylan to Supply Remdesivir Internationally
09:26pm, Tuesday, 12'th May 2020
Mylan (NASDAQ: MYL) announced on Tuesday that it has entered into a global partnership with Gilead Sciences (NASDAQ: GILD) to manufacture and distribute remdesivir in 127 low- and middle-income countr
Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19
08:16pm, Tuesday, 12'th May 2020
Mylan N.V. (NASDAQ: MYL) today announced, as part of its ongoing efforts to support patients and public health needs during the COVID-19 pandemic, a global collaboration with Gilead Sciences to expand
Is Mylan (MYL) Stock Undervalued Right Now?
03:50pm, Tuesday, 12'th May 2020
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Edited Transcript of MYL earnings conference call or presentation 11-May-20 2:30pm GMT
01:49am, Tuesday, 12'th May 2020
Q1 2020 Mylan NV Earnings Call
Mylan N.V. (MYL) Q1 2020 Earnings Call Transcript
09:30pm, Monday, 11'th May 2020
MYL earnings call for the period ending March 31, 2020.
Drug Stockpiling Lends Generic Pharma Stock A Boost — But Not Enough
08:21pm, Monday, 11'th May 2020
Drug stockpiling drove Mylan's sales 5% higher in the first quarter. Mylan stock rose despite its mixed report. Sales missed estimates, while adjusted profit narrowly beat expectations.
What's Behind Mylan's Mixed Q1 Results
05:00pm, Monday, 11'th May 2020
You might say that Mylan (NASDAQ: MYL) is a company in waiting. At some point over the next few months, its merger with Pfizer's Upjohn will close. Mylan will be no more; a new company named Viatri
Mylan (MYL) Beats on Q1 Earnings on Coronavirus-Led Stockpiling
02:53pm, Monday, 11'th May 2020
Mylan (MYL) beats on Q1 earnings but misses on sales.
Mylan (MYL) Q1 Earnings Top Estimates
01:45pm, Monday, 11'th May 2020
Mylan (MYL) delivered earnings and revenue surprises of 2.27% and -2.17%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Mylan Swings to Profit as Drug Sales Jump
01:32pm, Monday, 11'th May 2020
Shares of Mylan were rising Monday after the drug maker swung to a first quarter profit in the quarter as consumers stocked up on drugs during the coronavirus pandemic, but still fell just shy of rev
